22.02.2010 • News

Schlumberger, Smith Don't See Antitrust Sales

Schlumberger and Smith International do not expect to have to sell any major assets to get antitrust clearance for the oilfield services leader's acquisition of Smith, a source familiar with the deal said on Sunday.

Schlumberger earlier on Sunday announced a deal to buy Smith in an all-stock deal that values the company at about $11.3 billion. Commenting after the Wall Street Journal reported on Friday that Schlumberger was in talks to buy Smith, analysts said government antitrust enforcers could give the deal a hard look.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.